Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Campaign to Promote Genetic and Biomarker Testing for Breast Cancer with Jean Sachs Living Beyond Breast Cancer TRANSCRIPT
Download PDFSep 17, 2024
Jean Sachs, CEO of Living Beyond Breast Cancer, a national nonprofit organization dedicated to addressing disparities in cancer treatment and providing resources and support for individuals diagnosed with breast cancer. LBBC is part of the No One Missed breast cancer campaign, which aims to raise awareness about the importance of biomarker testing for metastatic breast cancer to help identify specific mutations in the tumor and develop a personalized treatment plan.
Jean explains, "We are so proud at Living Beyond Breast Cancer to be part of this campaign, founded and launched by LUNGevity Foundation in 2021. So, they are an organization that focuses on lung cancer. They wanted to get the word out about the importance of biomarker testing, particularly to those with non-small cell lung cancer, which is the non-smoking kind of lung cancer. They pulled together 25 organizations, created a website, ran a big campaign for a few years, and then realized that this kind of education campaign would be so beneficial to other types of cancers. So, we were very honored to be selected as the organization that would take the lead for the breast cancer community."
"Well, there are so many biomarker tests, and yes, they are more accurate, but this is important for anyone diagnosed with metastatic breast cancer. This is breast cancer that is beyond the breast. It’s in a vital organ, usually liver, lung, bone, or brain - it’s now considered an incurable disease. They have to ask their doctor if they have had a biomarker test or when they will have it because it can lead to finding specific mutations in the cancer tumor that might lead to a new treatment that they wouldn’t be eligible for unless they knew they had the mutation."
#NoOneMissed #LBBC #PersonalizedMedicine #Biomarker #BiomarkerTesting #MBC #MetastaticBreastCancer #BreastCancer #BreastCancerResources #CancerAwareness
